Moderna accuses Pfizer of copying patented technology behind Covid-19 vaccine in new lawsuit

The Cambridge company (Nasdaq: MRNA) alleged in a complaint filed in the U.S. District Court of Massachusetts Friday that Pfizer (NYSE: PFE) and BioNTech's vaccine, Comirnaty, violates three patents Moderna filed between 2010 and 2016.

Developer has Fort Lauderdale site under contract for 5-story storage facility

Prolific investor jumps into Mid-Market with $110 million deal for 1390 Market St. in San Francisco

Ikea to open small-format store in Pentagon City, delivery only

Tucson-based Accelerate Diagnostics to raise $35M in stock offering

Raleigh Beer Garden loses top spot to Charlotte

Breed says her new San Francisco housing plan will make people ‘feel uncomfortable’

What Baltimore realtors are watching during busy spring housing market

‘Mayor of Times Square’ Eli Marcus reflects on 4 decades in New York City hospitality

Moderna accuses Pfizer of copying patented technology behind Covid-19 vaccine in new lawsuit

Previous Lab Notes: Teleflex making acquisition valued at up to $300M; Vyant Bio files delayed quarterly report

Next Winery opening in Olde Kensington with big ambitions, Atlantic City steakhouse closing temporarily and other restaurant news

firststargroup

Kotek touts $500M Oregon housing plan at Leadership Summit

Retirement plans see boost as states mandate IRAs and tax credits lower costs

Norton Healthcare data breach affected more than 2 million people

Houston-based cell therapy company FibroBiologics files to go public

Suggested Posts

Arizona’s Largest FY 2022 SBA 504 Loans

Walmart notifies state of expected layoffs from closing Waterworks store

F.N.B. hires small business banking leader from PNC

$2 million home sales soar by over 50% in Dallas-Fort Worth

Bank of London to establish 350-job tech hub in Charlotte

Oddo Development wins final OK for first two phases of $300M Leawood project

MENU

FirstStar Group

More Stories

4EG launches downtown charity race